While, the TNFα/NF-kappa B signaling was not the only pathway for CBX7 to inhibit the tumor growth in ccRCC, the underlying mechanism by which CBX7 modulates the cancer progression needs to be performed in the furture. The gene discussed is CBX7; the disease is neoplasm.